ArticleOpen respiratory archives
Spain's Sarcoidosis Mortality: An Evolving Public Health Challenge.
Article in Open respiratory archives. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To comprehensively analyze national trends in sarcoidosis mortality in Spain between 1999 and 2023, with a focus on demographic differences and changes over time. Material and methods: This nationwide ecological study analyzed death registry data for sarcoidosis (ICD-10 code D86) from the Spanish National Institute of Statistics. Age-standardized mortality rates (ASMRs) were calculated by sex and age. Joinpoint regression assessed temporal trends and annual percentage changes (APCs). Results: Spain recorded 1053 sarcoidosis deaths between 1999 and 2023, with women accounting for 61.8%. Overall deaths rose, peaking at 72 in 2022. Mortality was heavily concentrated among those aged ≥ 65 years (75.8% of deaths). Age-specific mortality rates were negligible under 35, increasing markedly with age. Comparing 1999-2003 and 2019-2023 revealed rising mortality, especially among older adults; for example, men aged 70-74 saw rates increase from 1.22 to 4.06 per million, and women aged 80-84 from 3.24 to 8.40 per million. The male-to-female mortality ratio shifted over time, indicating a growing relative burden among men in several age groups. Joinpoint analysis showed steady ASMR increases: men's overall APC was +4.20%, driven by a 5.81% rise among those ≥65 years, while women's APC was +1.24%, primarily among those ≥65 years. Conclusions: Sarcoidosis mortality in Spain has risen substantially over 25 years, particularly among older adults and men. These findings underscore the need for targeted management and public health interventions focused on Spain's ageing population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.